Concepedia

Translational Assay Development

Translational Assay Development is a methodological framework within translational biomarker validation that establishes analytical and clinical performance characteristics of a biomarker assay to enable its progression from preclinical discovery to clinical application.

38

Publications

1.4K

Citations

243

Authors

119

Institutions

Publications per year

2017–2026

13

Parents

Publications

38

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

Jacob J. Kennedy, Susan E. Abbatiello, Kyunggon Kim et al. · Nature Methods · 2013 · 187 citations · Full text

, , +13

Analysis of interferon mRNA in human fibroblast cells induced to produce interferon.

Nitin Raj, Paula M. Pitha · Proceedings of the National Academy of Sciences · 1981 · 147 citations

, , +12

An RNA-Binding Protein Recognizes a Mammalian Selenocysteine Insertion Sequence Element Required for Cotranslational Incorporation of Selenocysteine

Andrea Lesoon, Anuradha Mehta, Rajnish Prakash Singh et al. · Molecular and Cellular Biology · 1997 · 82 citations

, , +13

Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC

Joe Yeong, Tira J. Tan, Zi Long Chow et al. · Journal of Clinical Pathology · 2020 · 74 citations · Full text

, , +13

Comparative study of the effects of heptameric slippery site composition on −1 frameshifting among different eukaryotic systems

Ewan P. Plant, Jonathan D. Dinman · RNA · 2006 · 57 citations · Full text

, , +15

1–5 of 38

Authors

243

  1. OG
    Oren Grad

    Wellesley College, United States

    2 publications · 65 citations

    2

    h-index

  2. AG
    Addison Greenwood

    St Bartholomew's Hospital, United Kingdom

    2 publications · 65 citations

    2

    h-index

  3. FF
    Frank Fan

    Promega (United States), United States

    1 publications · 34 citations

    1

    h-index

  4. SG
    Shalini Gupta

    VA Palo Alto Health Care System, United States

    1 publications · 19 citations

    1

    h-index

  5. SB
    Sanela Bilic

    Novartis (United States), United States

    1 publications · 16 citations

    1

    h-index

1–5 of 243

Institutions

119

  1. National Cancer Institute

    Bethesda, United States

    5 h-index

    6 publications

    327 citations

  2. Fred Hutch Cancer Center

    Seattle, United States

    3 h-index

    13 publications

    2K citations

  3. National Institutes of Health

    Bethesda, United States

    3 h-index

    3 publications

    252 citations

  4. Johns Hopkins University

    Baltimore, United States

    2 h-index

    3 publications

    328 citations

  5. Pfizer (United States)

    New York, United States

    2 h-index

    15 publications

    216 citations

  6. Wellesley College

    Wellesley, United States

    2 h-index

    2 publications

    65 citations

  7. Howard Hughes Medical Institute

    Chevy Chase, United States

    2 h-index

    4 publications

    188 citations

  8. Amgen (United States)

    Thousand Oaks, United States

    2 h-index

    3 publications

    50 citations

1–8 of 119

Venues

  1. Clinical Cancer Research

    2 publications · 65 citations

    2

    h-index

  2. Journal of Biological Chemistry

    JBC · 2 publications · 66 citations

    2

    h-index

  3. Archives of Medical Science

    AMS · 1 publications · 10 citations

    1

    h-index

  4. Analytical Chemistry

    1 publications · 35 citations

    1

    h-index

  5. British Journal of Clinical Pharmacology

    BJCP · 1 publications · 11 citations

    1

    h-index

1–5